Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 47Breast Neoplasms 6Leiomyoma 5Neoplasms 4Adenocarcinoma 2Uterine Neoplasms 1Urogenital Neoplasms 1Prostatic Diseases 1Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Myofibroma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lower Urinary Tract Symptoms 1Infertility 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1Genital Neoplasms, Male 1Carcinoma 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1

Interventions

Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Premenopausal Breast Cancer × Leuprolide × Clear all
NCT03209518 2019-11-01

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Takeda

Completed
312 enrolled 17 charts
Breast

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡